Biote Corp. Warrant
BTMDW
BTMDW was delisted on the 6th of July, 2023.
49 hedge funds and large institutions have $6.83M invested in Biote Corp. Warrant in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 7 closing their positions.
83% more capital invested
Capital invested by funds: $3.72M → $6.83M (+$3.11M)
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
9% more funds holding
Funds holding: 45 → 49 (+4)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
Top Sellers
BTMDW Hedge Fund Activity: Q4 2021 in Review
49 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Biote Corp. Warrant (BTMDW) for Q4 2021, worth a combined $6.83M — up 83% from $3.72M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BTMDW positions and 7 closed out — a net gain of 5 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $533K. The largest seller was Monashee Investment Management, exiting entirely with an estimated $101K sold.
- 49 institutional investors held Biote Corp. Warrant (BTMDW) as of Q4 2021, up from 45 in Q3 2021.
- Funds reported $6.83M of Biote Corp. Warrant stock for Q4 2021, up 83% quarter-over-quarter.
- 12 funds opened new Biote Corp. Warrant positions in Q4 2021 and 7 closed out, a net change of +5 holders.
- The largest Biote Corp. Warrant buyer in Q4 2021 was Glazer Capital LLC, an estimated $533K added.
- The largest Biote Corp. Warrant seller in Q4 2021 was Monashee Investment Management, an estimated $101K sold.
Based on aggregated 13F filings for Q4 2021.